GSTP1 is hypermethylated in nearly all human prostate cancers and its promoter DNA methylation level is able to differentiate between benign prostatic hyperplasia and different grades of prostate adenocarcinoma [6], [22], [23], [24], [25]. Here, GSTP1 is linked to prostate cancer.